Gyre Therapeutics (GYRE) Non-Current Assets (2010 - 2026)
Gyre Therapeutics (GYRE) recorded Non-Current Assets of $77.18 million in Q2 2026, up 25.8% from $61.36 million a year earlier and up 9.8% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics reported Non-Current Assets of $70.4 million, up 16.1% from FY2024.
- Annual Non-Current Assets has increased for four straight years, with a five-year compound annual growth rate of 67.5% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $60.62 million in FY2024 (+2.2%), $59.32 million in FY2023 (+69.0%), $35.1 million in FY2022 (+738.5%) and $4.19 million in FY2021 (-21.6%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2010.
- On a year-over-year basis, Non-Current Assets has increased for three consecutive quarters, with growth averaging 5.6% over the last seven quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 738.5% in Q4 2022, against a decline of 83.1% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $70.28 million (Q1 2026), $70.4 million (Q4 2025) and $60.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 77.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.18 Mn |
| Mar 31, 2026 | 70.28 Mn |
| Dec 31, 2025 | 70.40 Mn |
| Sep 30, 2025 | 60.81 Mn |
| Jun 30, 2025 | 61.36 Mn |
| Mar 31, 2025 | 61.34 Mn |
| Dec 31, 2024 | 60.62 Mn |
| Sep 30, 2024 | 70.43 Mn |
| Jun 30, 2024 | 67.41 Mn |
| Mar 31, 2024 | 59.29 Mn |
| Dec 31, 2023 | 59.32 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Mar 31, 2023 | 4.74 Mn |
| Dec 31, 2022 | 35.10 Mn |
| Sep 30, 2022 | 773,000.00 |
| Jun 30, 2022 | 2.07 Mn |
| Mar 31, 2022 | 3.57 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | 4.57 Mn |
API Access
Gyre Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();